|
| 37414703 | Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data. | Eur Urol | 2024 |
| 34547283 | Ectopic pregnancy prevention: Further evidence of benefits of prescription contraceptives. | Contraception | 2022 |
| 35379637 | Diagnostic and prognostic factors in patients with prostate cancer: a systematic review. | BMJ Open | 2022 |
| 35395215 | Association between intrauterine device type and risk of perforation and device expulsion: results from the Association of Perforation and Expulsion of Intrauterine Device study. | Am J Obstet Gynecol | 2022 |
| 35629173 | Secondary Treatment for Men with Localized Prostate Cancer: A Pooled Analysis of PRIAS and ERSPC-Rotterdam Data within the PIONEER Data Platform. | J Pers Med | 2022 |
| 35685531 | Time Trends and Treatment Pathways in Prescribing Individual Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: An Observational Study of More than Three Million Patients from Europe and the United States. | Int J Clin Pract | 2022 |
| 35939627 | Disparities in the Incidence of Ectopic Pregnancy in a Large Health Care System in California, 2010-2019. | Perm J | 2022 |
| 36357958 | Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion. | Obstet Gynecol | 2022 |
| 35226086 | Association of the Timing of Postpartum Intrauterine Device Insertion and Breastfeeding With Risks of Intrauterine Device Expulsion. | JAMA Netw Open | 2022 |
| 35184906 | Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium. | Eur Urol | 2022 |
| 35115001 | Evaluating the performance of temporal pattern discovery: new application using statins and rhabdomyolysis in OMOP databases. | BMC Med Inform Decis Mak | 2022 |
| 35292234 | Association between menorrhagia and risk of intrauterine device-related uterine perforation and device expulsion: results from the Association of Uterine Perforation and Expulsion of Intrauterine Device study. | Am J Obstet Gynecol | 2022 |
| 33460585 | Design of the Association of Uterine Perforation and Expulsion of Intrauterine Device study: a multisite retrospective cohort study. | Am J Obstet Gynecol | 2021 |
| 33574142 | Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol. | BMJ Open | 2021 |
| 34602368 | The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer. | Eur Urol Focus | 2021 |
| 34481969 | HIV viral load suppression following intensive adherence counseling among people living with HIV on treatment at military-managed health facilities in Uganda. | Int J Infect Dis | 2021 |
| 32470466 | Reduction in use of cyproterone/ethinylestradiol (Diane-35 and generics) after risk minimization measures in the Netherlands, UK and Italy. | Contraception | 2020 |
| 33141678 | Identifying Ectopic Pregnancy in a Large Integrated Health Care Delivery System: Algorithm Validation. | JMIR Med Inform | 2020 |
| 33305658 | Toward a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - part I: which parameters from human studies are most relevant for toxicological assessments? | Crit Rev Toxicol | 2020 |
| 32682423 | Feasibility study to identify women of childbearing age at risk of pregnancy not using any contraception in The Health Improvement Network (THIN) database. | BMC Med Inform Decis Mak | 2020 |
| 31032651 | Are risk minimization measures for approved drugs in Europe effective? A systematic review. | Expert Opin Drug Saf | 2019 |
| 31413641 | Identification and validation of uterine perforation, intrauterine device expulsion, and breastfeeding in four health care systems with electronic health records. | Clin Epidemiol | 2019 |
| 29663572 | A review of studies evaluating the effectiveness of risk minimisation measures in Europe using the European Union electronic Register of Post-Authorization Studies. | Pharmacoepidemiol Drug Saf | 2018 |
| 27769766 | Prescribing of cyproterone acetate/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network. | Contraception | 2017 |
| 29056853 | Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey. | Pharmaceut Med | 2017 |
| 28952198 | Thrombotic risk minimization for Diane-35 and generics. | Pharmacoepidemiol Drug Saf | 2017 |
| 28634990 | Clinical assessment to determine the risk of bowel cancer using Symptoms, Age, Mass and Iron deficiency anaemia (SAMI). | Br J Surg | 2017 |
| 26521865 | Literature review of visual representation of the results of benefit-risk assessments of medicinal products. | Pharmacoepidemiol Drug Saf | 2016 |
| 25539877 | Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network. | Drug Saf | 2015 |
| 24102361 | Diagnoses of gastrointestinal cancers after gastrointestinal bleeding in patients receiving clopidogrel or warfarin. | Curr Drug Saf | 2013 |
| 20883523 | Is earlier referral and investigation of bowel cancer patients presenting with rectal bleeding associated with better survival? | Colorectal Dis | 2011 |
| 21853828 | Weekend admission and mortality from acute exacerbations of chronic obstructive pulmonary disease in winter. | Clin Med (Lond) | 2011 |
| 21556787 | Routine laboratory tests can predict in-hospital mortality in acute exacerbations of COPD. | Lung | 2011 |
| 19123926 | Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy. | Malar J | 2009 |